Article citationsMore>>

Suzuki, K. and Kimura, H. (2018) TAK-063, a Novel PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides a Unique Opportunity for the Treatment of Schizophrenia. CNS Neuroscience & Therapeutics, 24, 604-614.
https://doi.org/10.1111/cns.12798

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top